| Literature DB >> 27292646 |
Cheng-Xu Delon Toh1, Jun-Wei Chan2, Zheng-Shan Chong2, Hao Fei Wang3, Hong Chao Guo4, Sandeep Satapathy2, Dongrui Ma5, Germaine Yen Lin Goh6, Ekta Khattar7, Lin Yang8, Vinay Tergaonkar9, Young-Tae Chang10, James J Collins11, George Q Daley12, Keng Boon Wee13, Chadi A El Farran3, Hu Li14, Yoon-Pin Lim15, Frederic A Bard16, Yuin-Han Loh17.
Abstract
Incomplete knowledge of the mechanisms at work continues to hamper efforts to maximize reprogramming efficiency. Here, we present a systematic genome-wide RNAi screen to determine the global regulators during the early stages of human reprogramming. Our screen identifies functional repressors and effectors that act to impede or promote the reprogramming process. Repressors and effectors form close interacting networks in pathways, including RNA processing, G protein signaling, protein ubiquitination, and chromatin modification. Combinatorial knockdown of five repressors (SMAD3, ZMYM2, SFRS11, SAE1, and ESET) synergistically resulted in ∼85% TRA-1-60-positive cells. Removal of the novel splicing factor SFRS11 during reprogramming is accompanied by rapid acquisition of pluripotency-specific spliced forms. Mechanistically, SFRS11 regulates exon skipping and mutually exclusive splicing of transcripts in genes involved in cell differentiation, mRNA splicing, and chromatin modification. Our study provides insights into the reprogramming process, which comprises comprehensive and multi-layered transcriptional, splicing, and epigenetic machineries.Entities:
Keywords: SFRS11; ZNF207; genome-wide siRNA screen; human somatic cell reprogramming; reprogramming specific alternative splicing
Mesh:
Substances:
Year: 2016 PMID: 27292646 DOI: 10.1016/j.celrep.2016.05.049
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423